Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cancer × Topotecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 78 Small Cell Lung Carcinoma 68 Neuroblastoma 38 Carcinoma, Ovarian Epithelial 38 Lung Neoplasms 35 Fallopian Tube Neoplasms 32 Neoplasms 28 Uterine Cervical Neoplasms 25 Leukemia 19 Brain Neoplasms 17 Recurrence 16 Leukemia, Myeloid, Acute 16 Sarcoma 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Glioma 11 Sarcoma, Ewing 10 Neoplasm Metastasis 10 Lymphoma 10 Retinoblastoma 9 Central Nervous System Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Medulloblastoma 8 Unspecified Adult Solid Tumor, Protocol Specific 7 Neuroectodermal Tumors, Primitive, Peripheral 7 Myelodysplastic Syndromes 7 Endometrial Neoplasms 7 Rhabdomyosarcoma 6 Lymphoma, Follicular 6 Leukemia, Myelomonocytic, Chronic 6 Burkitt Lymphoma 6

Interventions

Nivolumab 15 Surveys and Questionnaires 7 Ipilimumab 7 linrodostat 5 Standard of Care 5 Paclitaxel 5 Bevacizumab 5 temsirolimus 4 Sirolimus 4 Interviews as Topic 4 Gemcitabine 4 Docetaxel 4 relatlimab 3 Vorinostat 3 Pemetrexed 3 Erlotinib Hydrochloride 3 Cetuximab 3 Carboplatin 3 ARRY-334543 3 regorafenib 2 apatinib 2 abemaciclib 2 Trastuzumab 2 Sunitinib 2 Sorafenib 2 Olanzapine 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00770731 2013-02-13

Study of Temsirolimus, Topotecan, and Bortezomib

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡